Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The biopharmaceutical sector today is characterized by its intricacy, driven by increasing demands for enhanced specificity and safety, the emergence of new treatment classes, and the complexity of disease mechanisms. To navigate this intricate landscape, a profound comprehension of therapeutic dynamics is essential. Advanced modeling and simulation techniques offer a distinctive approach to investigate biological and physicochemical phenomena at the atomic scale. This methodology not only informs physical experimentation but also expedites the drug discovery and development phases. BIOVIA Discovery Studio integrates more than three decades of peer-reviewed research with cutting-edge in silico methodologies, including molecular mechanics, free energy assessments, and biotherapeutics developability, all within a unified framework. By equipping researchers with a comprehensive suite of tools, it facilitates a deeper examination of protein chemistry, thereby accelerating the discovery of both small and large molecule therapeutics, from Target Identification all the way through to Lead Optimization. Ultimately, this synergy of research and technology underscores the vital role of innovative tools in transforming biopharmaceutical advancements.
Description
Zochi stands out as the first autonomous AI system capable of completing the entire scientific research cycle, ranging from formulating hypotheses to achieving peer-reviewed publication, while generating cutting-edge outcomes. In contrast to previous systems that were confined to specific, well-defined tasks, Zochi thrives in confronting research challenges that are at the cutting edge of artificial intelligence. The system's effectiveness is demonstrated through a series of peer-reviewed papers accepted at the ICLR 2025 workshops, highlighting Zochi's capacity to produce innovative and academically sound contributions. Furthermore, Zochi recognized a significant obstacle within the AI field: the issue of cross-skill interference during parameter-efficient fine-tuning. This problem arises when models are adapted for multiple tasks at once, leading to enhancements in one skill that may negatively impact others. To combat this challenge, Zochi introduced a novel approach called CS-ReFT (Compositional Subspace Representation Fine-tuning), which emphasizes the editing of representations instead of altering weights. This groundbreaking method has the potential to revolutionize how AI systems are fine-tuned for diverse applications.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Dassault Systèmes
Founded
1981
Country
France
Website
www.3ds.com/products-services/biovia/products/molecular-modeling-simulation/biovia-discovery-studio/
Vendor Details
Company Name
Intology
Founded
2025
Country
United States
Website
www.intology.ai/blog/zochi-tech-report
Product Features
Product Features
Artificial Intelligence
Chatbot
No
For Healthcare
No
For Sales
No
For eCommerce
No
Image Recognition
No
Machine Learning
No
Multi-Language
No
Natural Language Processing
No
Predictive Analytics
No
Process/Workflow Automation
No
Rules-Based Automation
No
Virtual Personal Assistant (VPA)
No